27 April 2026CompletedHealthcare
Oncotelic Therapeutics, Inc. to acquire Neurobridge IP Holdings Incorporated
Oncotelic Therapeutics, Inc. and Neurobridge IP Holdings Incorporated entered the Exit Mode archive.
- Buyer
- Oncotelic Therapeutics, Inc.
- Target
- Neurobridge IP Holdings Incorporated
- Deal value
- USD 20,000,000
- Deal type
- strategic acquisition